4.3 Article

Strains of Epstein-Barr virus infecting multiple sclerosis patients

期刊

MULTIPLE SCLEROSIS JOURNAL
卷 16, 期 6, 页码 643-651

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458510364537

关键词

amino acid; Epstein-Barr virus; multiple sclerosis; sequence polymorphism; viral infections; viral gene

资金

  1. National Health and Medical Research Council, Australia [389830, 442902]
  2. Multiple Sclerosis Research Australia

向作者/读者索取更多资源

Both epidemiological and experimental studies have indicated that the ubiquitous herpesvirus Epstein-Barr virus (EBV) plays a role in the pathogenesis of multiple sclerosis (MS). Some features of MS epidemiology, such as the decline in risk among migrants from high to low MS prevalence areas, suggest the presence of variant EBV strains that increase MS risk. The objective of this study was to investigate whether genetic variability in EBV is associated with MS. Genes encoding for two EBV antigens (EBNA1 and BRRF2) were sequenced in EBV isolates from 40 MS patients and a similar number of control subjects. These viral antigens were chosen for analysis because they are known to stimulate atypical immune responses in MS. Extensive sequence polymorphism was observed within the EBNA1 and BRRF2 genes in isolates from both MS patients and controls. Interestingly, several single nucleotide polymorphisms within the EBNA1 gene, and one within the BRRF2 gene, were found to occur at marginally different frequencies in EBV strains infecting MS patients versus controls. Although this study does not find a simple causal relationship between EBV strains and the occurrence of MS, the existence of haplotypes that occur at different frequencies in MS patients versus controls may provide an area for future study of the role of EBV strain variation in multiple sclerosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medical Laboratory Technology

Molecular signature of interleukin-22 in colon carcinoma cells and organoid models

Ina Rudloff, Thierry Jarde, Malte Bachmann, Kirstin D. Elgass, Genevieve Kerr, Rebekah Engel, Elizabeth Richards, Karen Oliva, Simon Wilkins, Paul J. McMurrick, Helen E. Abud, Heiko Muehl, Marcel F. Nold

TRANSLATIONAL RESEARCH (2020)

Article Medicine, General & Internal

Patient-Derived Colorectal Cancer Organoids Upregulate Revival Stem Cell Marker Genes Following Chemotherapeutic Treatment

Rebekah M. Engel, Wing Hei Chan, David Nickless, Sara Hlavca, Elizabeth Richards, Genevieve Kerr, Karen Oliva, Paul J. McMurrick, Thierry Jarde, Helen E. Abud

JOURNAL OF CLINICAL MEDICINE (2020)

Article Gastroenterology & Hepatology

Predictive factors of complete pathological response in patients with locally advanced rectal cancer

Rebekah M. Engel, Karen Oliva, Christine Koulis, Raymond Yap, Paul J. McMurrick

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)

Article Multidisciplinary Sciences

Clostridioides difficile infection damages colonic stem cells via TcdB, impairing epithelial repair and recovery from disease

Steven J. Mileto, Thierry Jarde, Kevin O. Childress, Jaime L. Jensen, Ashleigh P. Rogers, Genevieve Kerr, Melanie L. Hutton, Michael J. Sheedlo, Sarah C. Bloch, John A. Shupe, Katja Horvay, Tracey Flores, Rebekah Engel, Simon Wilkins, Paul J. McMurrick, D. Borden Lacy, Helen E. Abud, Dena Lyras

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Oncology

Personalized Medicine-Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer

Christine Koulis, Raymond Yap, Rebekah Engel, Thierry Jarde, Simon Wilkins, Gemma Solon, Jeremy D. Shapiro, Helen Abud, Paul McMurrick

CANCERS (2020)

Article Biochemistry & Molecular Biology

Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells

Toshinobu Nishimura, Haojun Xu, Masayuki Iwasaki, Daiki Karigane, Brandon Saavedra, Yusuke Takahashi, Fabian P. Suchy, Shinichiro Monobe, Renata M. Martin, Manami Ohtaka, Mahito Nakanishi, Scott R. Burrows, Michael L. Cleary, Ravindra Majeti, Akira Shibuya, Hiromitsu Nakauchi

GENE THERAPY (2020)

Correction Medicine, Research & Experimental

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis (vol 3, e124714, 2018)

Michael P. Pender, Peter A. Csurhes, Corey Smith, Nanette L. Douglas, Michelle A. Neller, Katherine K. Matthews, Leone Beagley, Sweera Rehan, Pauline Crooks, Tracey J. Hopkins, Stefan Blum, Kerryn A. Green, Zara A. Ioannides, Andrew Swayne, Blake T. Aftab, Kaye D. Hooper, Scott R. Burrows, Kate M. Thompson, Alan Coulthard, Rajiv Khanna

JCI INSIGHT (2020)

Article Clinical Neurology

Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy

Zara A. Ioannides, Peter A. Csurhes, Nanette L. Douglas, Gem Mackenroth, Andrew Swayne, Kate M. Thompson, Tracey J. Hopkins, Kerryn A. Green, Stefan Blum, Kaye D. Hooper, Kerstin H. Wyssusek, Alan Coulthard, Michael P. Pender

Summary: The study shows that autologous EBV-specific T cell therapy is well-tolerated and can lead to sustained clinical improvement, including reduced fatigue and improved Expanded Disability Status Scale score in MS patients. More sustained improvement is associated with higher EBV-specific CD8(+) T cell reactivity in the administered T cell product.

FRONTIERS IN NEUROLOGY (2021)

Review Oncology

Estimating the global burden of Epstein-Barr virus-related cancers

Yide Wong, Michael T. Meehan, Scott R. Burrows, Denise L. Doolan, John J. Miles

Summary: More than 90% of the adult population globally is chronically infected by the Epstein-Barr virus (EBV), which is associated with various malignancies. This review focuses on six cancers with a relatively large EBV-related case burden and estimates the new cases and deaths in 2020. The findings highlight the significant global impact of EBV-related cancers and suggest potential for EBV-specific therapeutic interventions.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)

Article Gastroenterology & Hepatology

Modeling colorectal cancer: A bio-resource of 50 patient-derived organoid lines

Rebekah M. Engel, Thierry Jarde, Karen Oliva, Genevieve Kerr, Wing Hei Chan, Sara Hlavca, David Nickless, Stuart K. Archer, Raymond Yap, Pravin Ranchod, Stephen Bell, Ann Niap, Christine Koulis, Ashley Chong, Simon Wilkins, Trevor C. Dale, Andrew J. Hollins, Paul J. McMurrick, Helen E. Abud

Summary: Patient-derived colorectal cancer organoids (PDCOs) have the potential utility in personalized cancer medicine, as they recapitulate key characteristics of the primary tumor and can be used as a powerful tool for cancer research.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Cell & Tissue Engineering

Intestinal stem cell aging signature reveals a reprogramming strategy to enhance regenerative potential

Christian M. Nefzger, Thierry Jarde, Akanksha Srivastava, Jan Schroeder, Fernando J. Rossello, Katja Horvay, Mirsada Prasko, Jacob M. Paynter, Joseph Chen, Chen-Fang Weng, Yu B. Y. Sun, Xiaodong Liu, Eva Chan, Nikita Deshpande, Xiaoli Chen, Y. Jinhua Li, Jahnvi Pflueger, Rebekah M. Engel, Anja S. Knaupp, Kirill Tsyganov, Susan K. Nilsson, Ryan Lister, Owen J. L. Rackham, Helen E. Abud, Jose M. Polo

Summary: The impact of aging on intestinal stem cells is not fully understood. This study identified widespread epigenetic and transcriptional alterations in old ISCs. Key transcription factors were identified that drive molecular and functional differences between old and young states. These findings contribute to enhancing the regenerative capacity of intestinal stem cells.

NPJ REGENERATIVE MEDICINE (2022)

Article Gastroenterology & Hepatology

Impact of Anastomotic Leak on Long-term Oncological Outcomes After Restorative Surgery for Rectal Cancer: A Retrospective Cohort Study

Rebekah M. Engel, Karen Oliva, Suellyn Centauri, Wei Wang, Paul J. McMurrick, Raymond Yap

Summary: The aim of this study was to identify risk factors for anastomotic leak after rectal cancer surgery and assess its impact on perioperative and long-term oncological outcomes. A retrospective analysis was performed on data from 693 patients and it was found that the anastomotic leak rate was 3.75%. Male gender, hypertension, and ischemic heart disease were identified as risk factors for anastomotic leak. Anastomotic leak was associated with increased reoperation, hospital readmission, and inpatient death rates, as well as negatively impacting disease-free and overall survival.

DISEASES OF THE COLON & RECTUM (2023)

Article Surgery

Comparison of quality of life, symptom and functional outcomes following surgical treatment for colorectal neoplasia

Christine Georges, Raymond Yap, Stephen Bell, Keith Chip Farmer, Lauren C. L. Cohen, Simon Wilkins, Suellyn Centauri, Rebekah Engel, Karen Oliva, Paul J. McMurrick

Summary: This retrospective study evaluated the impact of four colorectal surgical procedures on patient-reported outcome measures. The study found that patients who underwent a right hemicolectomy had the best post-operative function and reduced symptoms, while patients who underwent an ultra-low anterior resection or an abdominoperineal resection had the worst outcomes.

ANZ JOURNAL OF SURGERY (2023)

Article Clinical Neurology

Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis

Zara A. Ioannides, Peter A. Csurhes, Andrew Swayne, Philippe Foubert, Blake T. Aftab, Michael P. Pender

Summary: In patients with multiple sclerosis (MS), the level of sTREM-2 in the cerebrospinal fluid (CSF) is positively correlated with T cell activation (sCD27), neuroaxonal damage (NfL and pNfH), disability (EDSS), and disease severity (MSSS).

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2021)

暂无数据